Novo Nordisk

Gains And Losses Linked To Associated Undertakings

This report examines where in the income statement gains and losses linked to an associate, that are separate from the share of profit or loss of the associate, are presented.

Novo Nordisk A/S Period End 31 December 2010

Submitted by Alisdair on Wed, 2011-04-06 07:43
Novo Nordisk A/S Annual Report 2010
Gain on disposal included in share of profit of associates income statement line item
Danish healthcare company Novo Nordisk includes a DKK1.06 billion gain on disposal of an associate in its income statement line share of profit of associated companies.

Novo Nordisk A/S Period End 31 December 2009

Submitted by Company Reporting on Wed, 2010-03-31 14:00
Aggregation criteria applied to disclosure of other comprehensive income and tax effects
Danish healthcare company Novo Nordisk applies aggregation to the components and tax effects of other comprehensive income that, on the face of it, conflicts with IFRS but tells us that this is on the grounds of materiality.